APD
40
-15
TXN
43
10
ETR
52
6
NRG
65
3
DVN
25
7
LYB
51
19
F
46
4
C
40
4
YUM
52
9
KR
40
-10
AMGN
57
11
EXC
50
3
USB
46
9
GWW
44
-2
TGNA
61
3
K
33
3
ZTS
54
5
AZO
63
11
DUK
64
5
HIG
74
2
APD
40
-15
TXN
43
10
ETR
52
6
NRG
65
3
DVN
25
7
LYB
51
19
F
46
4
C
40
4
YUM
52
9
KR
40
-10
AMGN
57
11
EXC
50
3
USB
46
9
GWW
44
-2
TGNA
61
3
K
33
3
ZTS
54
5
AZO
63
11
DUK
64
5
HIG
74
2
Financhill
Back

Seritage Growth Properties Vs. Viking Therapeutics Industry Stock Comparison

Sell
23

SRG
Seritage Growth Properties

Last Price:
4.49
Seasonality Move:
17.59%
Sell
48

VKTX
Viking Therapeutics

Last Price:
47.78
Seasonality Move:
1.76%
Sell
23
Seritage Growth Properties (SRG) is a Sell

Is Seritage Growth Properties a Buy, Sell or Hold?

  • The current Seritage Growth Properties [SRG] share price is $4.62. The Score for SRG is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • SRG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $52.12. The Score for VKTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRG Stock Price Chart

What is Seritage Growth Properties's stock price today?

  • The Seritage Growth Properties share price today is $4.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRG is experiencing slight selling pressure.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $52.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.

SRG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 11.42 Sell
Chaikin Money Flow: -59951 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.78 - 5.66) Sell
Bollinger Bands (100): (6.38 - 10.08) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.31 Sell
Relative Strength Index (14 RSI): 35.22 Sell
Chaikin Money Flow: -1197452 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.51 - 63.59) Sell
Bollinger Bands (100): (44.63 - 79.85) Sell

SRG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.76 Sell
20-day SMA: 5.04 Sell
50-day SMA: 7.05 Sell
200-day SMA: 8.35 Sell
8-day EMA: 4.78 Sell
20-day EMA: 5.25 Sell
50-day EMA: 6.51 Sell
200-day EMA: 8.19 Sell

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.81 Buy
20-day SMA: 56.4 Sell
50-day SMA: 65.08 Sell
200-day SMA: 38.5 Buy
8-day EMA: 52.52 Sell
20-day EMA: 56.3 Sell
50-day EMA: 61.03 Sell
200-day EMA: 45.53 Buy

Seritage Growth Properties Earnings Growth & SRG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.44 per share.

Seritage Growth Properties Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):